PD Dr. Jörg Distler



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages (2015) Beyer C, Huang J, Beer J, Zhang Y, Palumbo-Zerr K, Zerr P, Distler A, et al. Journal article Common German language nomenclature for systemic sclerosis (2015) Aringer M, Mueller-Ladner U, Burkhardt H, Distler J, Distler O, Graninger WB, Guenther C, et al. Journal article The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis (2014) Avouac J, Palumbo-Zerr K, Ruzehaji N, Tomcik M, Zerr P, Dees C, Distler A, et al. Journal article SIGNATURE OF CIRCULATING MICRORNAS IN OSTEOARTHRITIS (2014) Beyer C, Zampetaki A, Lin NY, Kleyer A, Perricone C, Iagnocco AM, Distler A, et al. Conference contribution Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability (2014) Distler A, Lang V, Del Vecchio T, Huang J, Zhang Y, Beyer C, Lin NY, et al. Journal article Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis (2014) Moinzadeh P, Aberer E, Ahmadi-Simab K, Blank N, Distler J, Fierlbeck G, Genth E, et al. Journal article Epigenetic modifications in autoimmune diseases (2014) Ramming A, Distler J, Schett G, Gay S, Jüngel A Journal article A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility (2014) Lopez-Isac E, Bossini-Castillo L, Simeon CP, Victoria Egurbide M, Jose Alegre-Sancho J, Luis Callejas J, Andres Roman-Ivorra J, et al. Journal article Deciphering the pro-fibrotic phenotype of fibroblasts in systemic sclerosis (2014) Maier C, Distler J, Beyer C Journal article The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis (2014) Dees C, Schlottmann I, Funke R, Distler A, Palumbo-Zerr K, Zerr P, Lin NY, et al. Journal article